Captrust Financial Advisors Corcept Therapeutics Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 103,740 shares of CORT stock, worth $5.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

103,740

Previous 122,995 15.66%

Holding current value

$5.41 Million

Previous $4 Million 20.1%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $568,215 - $890,736	-19,255 Reduced 15.66%	103,740 $4.8 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $148,273 - $230,188	-6,676 Reduced 5.15%	122,995 $4 Million
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $261,661 - $340,531	-12,401 Reduced 8.73%	129,671 $3.27 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $22,536 - $29,855	-908 Reduced 0.64%	142,072 $4.61 Million
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $1.87 Million - $2.88 Million	-85,187 Reduced 37.34%	142,980 $3.9 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $13,314 - $15,618	621 Added 0.27%	228,167 $5.08 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $4.01 Million - $5.11 Million	208,844 Added 1116.69%	227,546 $4.93 Million
Q4 2022 Feb 15, 2023	BUY	$19.95 - $29.96 $2,932 - $4,404	147 Added 0.79%	18,702 $379,000
Q3 2022 Nov 16, 2022	BUY	$24.7 - $29.12 $269,798 - $318,077	10,923 Added 143.12%	18,555 $476,000
Q2 2022 Aug 23, 2022	SELL	$17.33 - $25.3 $119,074 - $173,836	-6,871 Reduced 47.38%	7,632 $181,000
Q2 2022 Aug 16, 2022	BUY	$17.33 - $25.3 $133,406 - $194,759	7,698 Added 113.12%	14,503 $345,000
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $52,581 - $80,193	3,181 Added 87.78%	6,805 $153,000
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $4,377 - $5,975	256 Added 7.6%	3,624 $72,000
Q3 2021 Nov 16, 2021	BUY	$19.68 - $22.53 $728 - $833	37 Added 1.11%	3,368 $66,000
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $12,860 - $15,732	-644 Reduced 16.2%	3,331 $73,000
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $88,204 - $114,752	3,755 Added 1706.82%	3,975 $95,000
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $1,678 - $2,730	100 Added 83.33%	220 $6,000
Q3 2020 Nov 17, 2020	BUY	$12.46 - $19.98 $1,495 - $2,397	120 New	120 $2,000

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.59B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Corcept Therapeutics Inc Transaction History